Phase IV clinical studies
Term · Chemistry · MLC-T-CHM-008745
Post-marketing surveillance studies conducted after a drug has been approved and released to the market. These studies monitor the long-term safety and effectiveness of the drug in a real-world setting. They can identify rare adverse effects or new indications not observed in earlier clinical phases.
| Identifier | MLC-T-CHM-008745 |
|---|---|
| Field | Chemistry |
| Subject | Chemistry and Human Health |
| References | PAC, 2013, 85, 1725. 'Glossary of terms used in medicinal chemistry. Part II (IUPAC Recommendations 2013)' on page 1746 (https://doi.org/10.1351/PAC-REC-12-11-23) |
| See also | Phase 0 clinical studies; Phase I clinical studies; Phase II clinical studies; Phase III clinical studies |
Record as JSON
{
"id": "MLC-T-CHM-008745",
"term": "Phase IV clinical studies",
"field": "Chemistry",
"definition": "Post-marketing surveillance studies conducted after a drug has been approved and released to the market. These studies monitor the long-term safety and effectiveness of the drug in a real-world setting. They can identify rare adverse effects or new indications not observed in earlier clinical phases.",
"subject": "Chemistry and Human Health",
"see_also": [
"phase 0 clinical studies",
"phase I clinical studies",
"phase II clinical studies",
"phase III clinical studies"
],
"references": [
"PAC, 2013, 85, 1725. 'Glossary of terms used in medicinal chemistry. Part II (IUPAC Recommendations 2013)' on page 1746 (https://doi.org/10.1351/PAC-REC-12-11-23)"
],
"url": "https://mlchart.com/terminology/chemistry/phase-iv-clinical-studies/"
}
Record 9,282 of 13,676 in Chemistry terminology (MLC-0109). Request the full dataset.